Bone News and Research

RSS

New technology that increases Natural Killer cells to stop cancers gets licensed

Our bodies contain Natural Killer (NK) cells - an army that stops cancers and viruses before they can make us sick.

15 Dec 2016

UC San Diego engineers develop innovative method to detect infections in prostheses

Engineers at the University of California San Diego have developed a new non-invasive method to detect infections in prostheses used for amputees, as well as for knee, hip and other joint replacements.

15 Dec 2016

Technological advancements in hearing implants

Hearing aids capture sound, make the sound louder and then send the sound down the ear canal, through the middle ear to the inner ear where the hearing nerves are located. They are most beneficial for people with mild to moderate hearing loss...

14 Dec 2016

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.

14 Dec 2016

Research redefines role of Spop protein during bone development

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes -- a condition known as brachydactyly. T

9 Dec 2016

Defective ribosomes linked to aggressive form of multiple myeloma

20 to 40 percent of the patients with multiple myeloma - a type of leukaemia - have a defect in the ribosome, the protein factory of the cell.

9 Dec 2016

Curasan reveal plan for orthopedic product campaign

Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States.

9 Dec 2016

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

A personalized cancer vaccine markedly improved outcomes for patients suffering from acute myeloid leukemia (AML), a potentially lethal blood cancer, in a clinical trial led by investigators at Beth Israel Deaconess Medical Center.

9 Dec 2016

Endocrine Society applauds Novo Nordisk for pledging to limit rising insulin prices

The Endocrine Society lauds Novo Nordisk's recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue.

From Novo Nordisk 8 Dec 2016

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Leukemia researchers at Princess Margaret Cancer Centre have developed a 17-gene signature derived from leukemia stem cells that can predict at diagnosis if patients with acute myeloid leukemia (AML) will respond to standard treatment.

8 Dec 2016

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma

Scientists have found a way to detect earlier if a deadly cancer, Merkel cell carcinoma (MCC), is recurring in patients, according to a paper to be published 11 a.m. Eastern time, Dec. 7, in the journal Cancer.

7 Dec 2016

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

Two genetic mutations known to play a role in many solid cancers might also help explain why a subset of acute myeloid leukemia (AML) patients develop the disease, according to new research from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute.

7 Dec 2016

New virtual reality technology may find potential use in diagnostics and surgical planning

Before an operation, surgeons have to obtain the most precise image possible of the anatomical structures of the part of the body undergoing surgery.

7 Dec 2016

Researchers unveil new role of thymic dendritic cells in controlling T lymphocyte egress into the blood

A team of scientists led by Julie Saba, MD, PhD at UCSF Benioff Children's Hospital Oakland, has unveiled a novel role of thymic dendritic cells, which could result in new strategies to treat conditions such as autoimmune diseases, immune deficiencies, prematurity, infections, cancer, and the loss of immunity after bone marrow transplantation.

6 Dec 2016

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Trial results being presented today during the 58th American Society of Hematology Annual Meeting and Exposition in San Diego suggest two therapies that are often added to standard therapy in patients with multiple myeloma do not improve rates of progression-free survival compared with the current standard course of treatment alone.

6 Dec 2016

Research findings point to inherited genetic basis of ALL risk in children

A late-breaking abstract being presented today during the 58th American Society of Hematology Annual Meeting and Exposition in San Diego identifies inherited genetic mutations in the gene IKZF1 that confer a higher likelihood of developing pediatric acute lymphocytic leukemia (ALL).

6 Dec 2016

Experimental T-cell therapy shows promise in preventing AML relapse

Fred Hutchinson Cancer Research Center announced promising results from an early trial in which patients with high-risk acute myeloid leukemia received genetically engineered immune cells.

6 Dec 2016

Simple, coordinated approach can improve chances of survival for high-risk AML patients

New research shows that quickly identifying patients with high-risk acute myeloid leukemia (AML), and speeding the process to find them a stem cell donor and performing the transplant earlier, can significantly improve their chances of surviving for at least two years after diagnosis without a relapse.

5 Dec 2016

Research validates effectiveness of world-first dental vaccine

A world-first vaccine developed by Melbourne scientists, which could eliminate or at least reduce the need for surgery and antibiotics for severe gum disease, has been validated by research published this weekend in a leading international journal.

5 Dec 2016

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Patients successfully treated for breast, colon and other cancers can go on to develop an often-fatal form of leukemia, sometimes years after completion of treatment, due to a genetic mutation leading to secondary malignancies known as therapy-related myeloid neoplasms (t-MNs).

4 Dec 2016

Bone News and Research

New technology that increases Natural Killer cells to stop cancers gets licensed

UC San Diego engineers develop innovative method to detect infections in prostheses

Technological advancements in hearing implants

Phenotypic Personalized Medicine could surmount treatment challenges for acute lymphoblastic leukemia

Research redefines role of Spop protein during bone development

Defective ribosomes linked to aggressive form of multiple myeloma

Curasan reveal plan for orthopedic product campaign

Personalized cancer vaccine improves outcomes for patients with AML, clinical study shows

Endocrine Society applauds Novo Nordisk for pledging to limit rising insulin prices

Stem cell-based risk scoring tool could predict AML patient’s response to standard treatment

Scientists find novel way for earlier detection of deadly Merkel cell carcinoma

New research reveals role of two genetic mutations in subset of acute myeloid leukemia

New virtual reality technology may find potential use in diagnostics and surgical planning

Researchers unveil new role of thymic dendritic cells in controlling T lymphocyte egress into the blood

Additions to standard therapy do not improve progression-free survival in patients with multiple myeloma

Research findings point to inherited genetic basis of ALL risk in children

Experimental T-cell therapy shows promise in preventing AML relapse

Simple, coordinated approach can improve chances of survival for high-risk AML patients

Research validates effectiveness of world-first dental vaccine

Clonal hematopoiesis may help predict cancer patients at risk for fatal form of leukemia

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News